Tobacco Control Conference in Panama: Focus on E-Cigarettes

Events by 2FIRSTS.ai
Feb.05.2024
Tobacco Control Conference in Panama: Focus on E-Cigarettes
The 10th World Conference on Tobacco Control in Panama focuses on tobacco advertising and new products, especially e-cigarettes.

According to media outlet Alwasat's report on February 4th, Panama is hosting the 10th World Tobacco Control Conference. The conference will take place near the Panama Canal, where experts will discuss tobacco advertising and new products, with a particular focus on the popular e-cigarette among young people.

 

According to a report from the World Health Organization (WHO), tobacco claims the lives of 8 million people globally every year, with 1.3 million of them being passive smokers. Experts are calling for more effective tobacco control measures. Ricardo Fabrega, former Deputy Minister of Health in Chile and Dean of the Health School at the University of Santo Tomas, stated that the attention given to the issue of smoking is still far from sufficient, considering the significant harm caused by tobacco.

 

Ruediger Krech, Director of the Department of Health Promotion at the World Health Organization (WHO), previously stated that although global tobacco consumption is decreasing, the tobacco industry is introducing new products that are more addictive, particularly targeting minors.

 

More than 70 participating countries will delve into the issue of eliminating illicit trade in tobacco products following the conclusion of the 10th World Conference on Tobacco Control. The focus will primarily be on the illegal manufacturing and sale of tobacco products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
Altria’s subsidiary NJOY has sued the U.S. Food and Drug Administration (FDA) and the U.S. Department of Health and Human Services (HHS), alleging prolonged delays in ruling on its appeal for flavored disposable vapes. NJOY argues the products are identical to authorized versions and backed by scientific data and safeguards, yet the review has taken far beyond statutory limits, blocking lawful products while illicit ones flood the market.
Aug.24
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
China’s nicotine pouch sector saw a sharp decline in exhibitors and traffic. Insiders cite tighter regulation and rising overseas competition, with many firms turning to Europe, the U.S., and the Middle East, and some building factories in Indonesia for growth.
Aug.28 by 2FIRSTS.ai
Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
A referendum to be held on November 4 will determine whether Denver retains its ban on the sale of flavored tobacco/nicotine products. Campaign finance records show that, as of the end of August, the side seeking to repeal the ban had raised $410,000, significantly more than the pro-ban side (about $245,000). The ban took effect in March 2025, but the city had planned to begin enforcement on January 2026; if the referendum overturns the ban, enforcement will not proceed.
Sep.25 by 2FIRSTS.ai
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
The latest data show that in 2024, disposable vape sales in Nova Scotia grew by 25%, and about 16% of residents use vaping products—signaling strong demand for tobacco alternatives. The province’s regulatory framework is forcing retailers to accelerate product-line adjustments and compliance upgrades.
Sep.23 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
2Firsts On-Site at InterTabac: Industry Suppliers Confident About Outlook Despite Stagnant Cigarette Volumes
2Firsts On-Site at InterTabac: Industry Suppliers Confident About Outlook Despite Stagnant Cigarette Volumes
At InterTabac 2025, 2Firsts spoke with traditional tobacco suppliers. Despite stagnant cigarette sales in many regions, they remained optimistic, believing that adapting to market shifts could help them grow in a shrinking sector. Many companies are now moving into emerging categories like nicotine pouches, roll-your-own, and heat-not-burn products, using innovation and infrastructure upgrades to meet changing consumer and regulatory demands.
Sep.22